Cochrane Abstracts
Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antenatal Phenobarbital for Reducing Neonatal Jaundice After Red Cell Isoimmunization." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437341/all/Antenatal_phenobarbital_for_reducing_neonatal_jaundice_after_red_cell_isoimmunization.
Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437341/all/Antenatal_phenobarbital_for_reducing_neonatal_jaundice_after_red_cell_isoimmunization. Accessed December 14, 2024.
Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437341/all/Antenatal_phenobarbital_for_reducing_neonatal_jaundice_after_red_cell_isoimmunization
Antenatal Phenobarbital for Reducing Neonatal Jaundice After Red Cell Isoimmunization [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437341/all/Antenatal_phenobarbital_for_reducing_neonatal_jaundice_after_red_cell_isoimmunization.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization
ID - 437341
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437341/all/Antenatal_phenobarbital_for_reducing_neonatal_jaundice_after_red_cell_isoimmunization
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
